Table 1.
Characteristics | Study arm A ('blended') |
Study arm B ('classical') |
'Control' Group (not randomised) |
|
---|---|---|---|---|
QCs | 13 | 13 | 4 | |
Sponsored by pharmaceutical industry | 5 | 4 | 0 | |
Training in dementia topics during the last 12 months | 2 | 1 | 1 | |
Meetings per year (median) | 6.7 | 6.5 | 6.5 | |
Average time between t0 and t1 in weeks (SD) ('control' group: t2') |
9.5 (± 3.7) | 8.5 (± 4.4) | 21 (± 4.0) | |
GPs | Participants (t0 and t1) |
84 | 82 | 21 (t0 and t2') |
Average age of participants in years (SD) | 51 (± 6.8) | 50.7 (± 7.5) | 49.3 (± 8.8) | |
Percentage of females | 29% | 28% | 43% | |
Single doctor practices (versus group practice) | 44% | 51% | 24% |